CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Anoop Patel

September 6, 2022

Anoop Patel joins Duke, CAGT

We are excited to welcome Anoop Patel, MD, associate professor of neurosurgery, to the CAGT community. Patel graduated magna cum laude from Harvard Medical School and completed residency as well as a research fellowship at Massachusetts General Hospital. He comes to Duke from University of [...]

July 1, 2022

Pranam Chatterjee Joins Duke, CAGT

We are excited to welcome Pranam Chatterjee, PhD, assistant professor of biomedical engineering, to the CAGT community.  Chatterjee's research focus explores how to develop cells and tissues that can improve reproductive longevity and fertility.  “The work that I do is very interdisciplinary, and I [...]